OrbiMed Capital GP VII LLC's Net Worth

$384 Million

Estimate Recalculated Feb 23, 2024 05:15PM EST

Who is OrbiMed Capital GP VII LLC?

OrbiMed Capital GP VII LLC has an estimated net worth of $384 Million. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., Fusion Pharmaceuticals Inc., Repare Therapeutics Inc., Arcutis Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Kinnate Biopharma Inc., Sierra Oncology, Inc., Synthorx, Inc., Terns Pharmaceuticals, Inc., Galecto, Inc., Passage BIO, Inc., Enliven Therapeutics, Inc., Janux Therapeutics, Inc., Third Harmonic Bio, Inc., and Pandion Therapeutics Holdco LLC.

SEC CIK

OrbiMed Capital GP VII LLC's CIK is 0001760648

Past Insider Trading and Trends

2020 was OrbiMed Capital GP VII LLC's most active year for acquiring shares with 36 total transactions. OrbiMed Capital GP VII LLC's most active month to acquire stocks was the month of December. 2023 was OrbiMed Capital GP VII LLC's most active year for disposing of shares, totalling 37 transactions. OrbiMed Capital GP VII LLC's most active month to dispose stocks was the month of March. 2020 saw OrbiMed Capital GP VII LLC paying a total of $106,373,691.00 for 30,545,108 shares, this is the most they've acquired in one year. In 2022 OrbiMed Capital GP VII LLC cashed out on 17,526,737 shares for a total of $133,513,360.13, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Keros Therapeutics, Inc. (KROS) Snapshot price: $52.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+170.39%
1.27M
$16.00
$6,003,200.00
2.01M
Apr 13
Form 3
0
0
No matching records found

Fusion Pharmaceuticals Inc. (FUSN) Snapshot price: $11.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.12M
$17.00
$3,265,700.00
3.12M
Jun 30
Form 3
0
0
No matching records found

Repare Therapeutics Inc. (RPTX) Snapshot price: $7.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.12%
-8.08K
$33.97
-$274,793.91
6.55M
Scheduled
Sep 3 - Sep 7
Form 4
-0.38%
-37.86K
$34.05
-$1,290,550.08
9.89M
Scheduled
Aug 31 - Sep 2
Form 4
-0.18%
-18.07K
$34.13
-$615,747.82
9.98M
Scheduled
Aug 26 - Aug 30
Form 4
-0.18%
-18.21K
$34.16
-$622,426.25
10.03M
Scheduled
Aug 23 - Aug 25
Form 4
-0.30%
-20.33K
$34.06
-$693,210.46
6.71M
Scheduled
Aug 17 - Aug 18
Form 4
3.38M
$20.00
$1,984,000.00
3.38M
Jun 23
Form 3
0
0
No matching records found

Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.745

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.97%
-341.97K
$21.31
-$7,287,402.01
3.95M
Jun 24
Form 4
-6.06%
-878.20K
$20.69
-$18,163,608.12
13.62M
Apr 6 - Apr 8
Form 4
+10.61%
496K
$25.00
$12,400,000.00
5.17M
Oct 2
Form 4
+836.28%
4.67M
$17.00
$9,501,096.00
5.23M
Feb 3 - Feb 4
Form 3
0
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-17.71M
0
Feb 14
Form 4
+2.78%
479.93K
$3.05
$1,463,792.60
17.71M
Jul 17
Form 4
+1.16%
192K
$5.21
$1,000,320.00
16.73M
Nov 7
Form 4
+0.97%
158.42K
$9.97
$1,578,717.49
16.54M
Jan 19 - Jan 21
Form 4
+0.27%
44.72K
$9.90
$442,750.42
16.38M
Jan 11 - Jan 13
Form 4
16.84M
$16.00
16.84M
Oct 12
Form 3
0
0
No matching records found